Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (2022 - 2025)

Tarsus Pharmaceuticals has reported Interest Coverage Ratio over the past 4 years, most recently at 3.6 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 3.6 for Q4 2025, up 65.89% from a year ago — trailing twelve months through Dec 2025 was 7.94 (up 48.29% YoY), and the annual figure for FY2025 was 7.94, up 48.29%.
  • Interest Coverage Ratio for Q4 2025 was 3.6 at Tarsus Pharmaceuticals, up from 6.41 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for TARS hit a ceiling of 3.6 in Q4 2025 and a floor of 61.78 in Q1 2022.
  • Median Interest Coverage Ratio over the past 4 years was 18.78 (2024), compared with a mean of 25.34.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 319.36% in 2023 and later soared 78.43% in 2024.
  • Tarsus Pharmaceuticals' Interest Coverage Ratio stood at 21.76 in 2022, then tumbled by 106.5% to 44.94 in 2023, then skyrocketed by 76.5% to 10.56 in 2024, then surged by 65.89% to 3.6 in 2025.
  • The last three reported values for Interest Coverage Ratio were 3.6 (Q4 2025), 6.41 (Q3 2025), and 9.9 (Q2 2025) per Business Quant data.